Physician profile
Disha Kumar
NPI 1952862658
$1,937.53
in general payments reported to CMS, 2019-2025
16 companies · $940 in 2025
The $940 reported for 2025 was more than what 87% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $124 · 2023: $182 · 2024: $691 · 2025: $940.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,813.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,813.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $427.37 | 2023-2025 | Entyvio, Gattex, Eohilia |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $269.02 | 2024-2025 | Xifaxan, Trulance |
| Janssen Biotech, INC. | $211.76 | 2025 | Tremfya |
| Abbvie INC. | $199.80 | 2024-2025 | |
| Conmed Corporation | $181.92 | 2023-2025 | Conmed Generators |
| Madrigal Pharmaceuticals | $143.63 | 2025 | Rezdiffra |
| Gilead Sciences, INC. | $124.40 | 2022 | |
| Merck Sharp & Dohme LLC | $120.01 | 2023-2024 | Dificid |
| Intercept Pharmaceuticals, INC. | $89.55 | 2024-2025 | |
| Boston Scientific Corporation | $62.50 | 2024-2025 | Apollo Esg System, Ams 700, Overstitch Endoscopic Suturing System |
| Genzyme Corporation | $21.51 | 2023 | |
| Alcresta Therapeutics, INC. | $21.07 | 2023 | Relizorb |
| Phathom Pharmaceuticals, INC. | $19.03 | 2024 | Voquezna |
| Novo Nordisk INC | $18.44 | 2025 | Wegovy |
| Ardelyx, INC. | $14.12 | 2024 | Ibsrela |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Redhill Biopharma INC. | $13.40 | 2023 | Talicia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Disha Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.